Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

KA Jacobson, ZG Gao, P Matricon… - British journal of …, 2022 - Wiley Online Library
A long evolution of knowledge of the psychostimulant caffeine led in the 1960s to another
purine natural product, adenosine and its A2A receptor. Adenosine is a short‐lived …

Highlights on the Development of A2A Adenosine Receptor Agonists and Antagonists

G Cristalli, B Cacciari, D Dal Ben… - ChemMedChem …, 2007 - Wiley Online Library
Although significant progress has been made in the past few decades demonstrating that
adenosine modulates a variety of physiological and pathophysiological processes through …

A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and …

G Cristalli, C Lambertucci, G Marucci… - Current …, 2008 - ingentaconnect.com
Since the discovery of the biological effects of adenosine, the development of potent and
selective agonists and antagonists of adenosine receptors has been the subject of medicinal …

[HTML][HTML] A3-adenosine receptors: design of selective ligands and therapeutic prospects

KA Jacobson, HO Kim, SM Siddiqi, ME Olah… - Drugs of the …, 1995 - ncbi.nlm.nih.gov
Adenosine A1 and A2 receptors have been the subject of intense activity in the
pharmaceutical industry. Adenosine agonists, which are almost exclusively derivatives of …

The A3 adenosine receptor: an enigmatic player in cell biology

S Gessi, S Merighi, K Varani, E Leung… - Pharmacology & …, 2008 - Elsevier
Adenosine is a primordial signaling molecule present in every cell of the human body that
mediates its physiological functions by interacting with 4 subtypes of G-protein-coupled …

Adenosine receptor ligands: differences with acute versus chronic treatment

KA Jacobson, DKJE von Lubitz, JW Daly… - Trends in …, 1996 - cell.com
Caffeine, the most widely consumed of all psychoactive drugs, is an adenosine receptor
antagonisP3. It is regu-larly ingested by more than half of the adult population in Western …

A2A adenosine receptor agonists and their potential therapeutic applications. An update

A Guerrero - Current medicinal chemistry, 2018 - ingentaconnect.com
Background: Adenosine is an endogenous purine nucleoside, which mediates a variety of
important biological processes and diseases, such as vasodilation, inflammation, cancer …

[PDF][PDF] Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain

S Ferre, F Ciruela, J Borycz, M Solinas, D Quarta… - Front Biosci, 2008 - researchgate.net
[Frontiers in Bioscience 13, 2391-2399, January 1, 2008] 2391 Adenosine A1-A2A receptor
heteromers: new targets for caffeine in Page 1 [Frontiers in Bioscience 13, 2391-2399, January …

[HTML][HTML] A2A adenosine receptor antagonists in neurodegenerative diseases

S Merighi, PA Borea, K Varani, F Vincenzi… - Current medicinal …, 2022 - ncbi.nlm.nih.gov
Background: Alzheimer's disease (AD) is the most common form of dementia worldwide,
with approximately 6 million cases reported in America in 2020. The clinical signs of AD …

Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system

P Popoli, R Pepponi - … (Formerly Current Drug Targets-CNS & …, 2012 - ingentaconnect.com
Adenosine A2B and, much more importantly, adenosine A2A receptors modulate many
physiological and pathological processes in the brain. In this review, the most recent …